Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Blood|July 9, 2008
Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndromeBart L Scott, Denise A Wells, Michael R Loken, et al.
Blood|March 19, 2015
Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosisNicolaus Kröger, Toni Giorgino, Bart L Scott, et al.
Blood|January 12, 2012
The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantationBart L Scott, Ted A Gooley, Mohamed L Sorror, et al.
Blood|March 5, 2026
Nonmyeloablative Conditioning Combined with Anti-CD117 Antibody Briquilimab in Older Adults with High-Risk AML and MDSLori S Muffly, Catherine J Lee, Arpita Gandhi, et al.
Blood|March 20, 2023
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantationNico Gagelmann, Anita Badbaran, Rachel B Salit, et al.
Blood|July 7, 2012
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDSH Joachim Deeg, Bart L Scott, Min Fang, et al.
Blood|May 10, 2007
Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disordersChunkang Chang, Barry E Storer, Bart L Scott, et al.
Blood|August 15, 2022
Germ line predisposition variants occur in myelodysplastic syndrome patients of all agesSimone Feurstein, Amy M Trottier, Noel Estrada-Merly, et al.
Pageof 1